Page 8 - Emergent Biosolution News Today

Written by Steven HansenThe U.S. new cases 7-day rolling average are 12.0 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 0.2 % LOWER than the rolling average one week ago. Todays posts include:

But manufacturing at Baltimore-area plant still not authorized under EUA, agency said

Federal regulators at the U.S. Food and Drug Administration will authorize for use two batches of Johnson & Johnson’s COVID-19 vaccine manufactured at the troubled Baltimore facility where critical production errors rendered millions of doses unusable earlier this year.

The Western Cape and KwaZulu-Natal are leading South Africa's vaccine rate and are the only provinces exceeding the national average.

Education staff will not receive the J&J Covid-19 vaccine in the week of 7 June – even if 480 000 doses, which J&J offered SA as a replacement for some of the country's potentially contaminated jabs, arrive next week.

NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has ...

The Latest: WTO: Develop vaccines in Africa, Latin America By The Associated Press BRUSSELS — The head of the World Trade Organization says it’s paramount to diversify vaccine manufacturing and develop production in Africa and Latin America to contain the coronavirus pandemic. On the eve of a global health summit in Rome, WTO Director-General Ngozi Okonjo-Iweala told European Union legislators on Thursday that normal market forces for exports and imports can’t apply when it comes to the l...

FOXBOROUGH, Mass. — A distinct geographic pattern has emerged in the U.S. drive to vanquish the coronavirus - the highest vaccination rates are concentrated in the Northeast, while the lowest are mostly in the South. Experts say the gap reflects a multitude of factors, including political leanings, religious beliefs, and education and income levels. Close to 160 million Americans — 48% of the population — have received at least one dose of a COVID-19 vaccine, and 125 million are ...

NEW YORK, NY / ACCESSWIRE / May 20, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. ("Emergent" or "the Company") (NYSE:EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between July 6, 2020 and March 31, 2021, both dates inclusive (the "Class Period").

European Union to open for vaccinated travelers; Dr. Anthony Fauci says public misinterpreting CDC mask guidance: Latest COVID-19 updates Ndea Yancey-Bragg and Jorge L. Ortiz, USA TODAY Retailers make way for mask-free shopping after new CDC guidance Replay Video UP NEXT The European Union on Wednesday announced plans to reopen its borders to fully vaccinated visitors, as well as people coming from a list of countries considered safe, with the United States expected to make t...